Title:
経皮送達用医薬組成物
Document Type and Number:
Japanese Patent JP3778937
Kind Code:
B2
Abstract:
PCT No. PCT/FR96/00480 Sec. 371 Date Dec. 3, 1997 Sec. 102(e) Date Dec. 3, 1997 PCT Filed Mar. 29, 1996 PCT Pub. No. WO96/30000 PCT Pub. Date Oct. 3, 1996The invention concerns a pharmaceutical composition for transdermal administration, characterized in that it comprises: a) optionally, a polymeric release matrix capable of forming a flexible film after drying, chosen from cellulose polymers or copolymers or vinylpyrrolidone/vinyl acetate copolymers b) an active principle c) a promoter of transcutaneous absorption of the active principle d) a physiologically acceptable non-aqueous solvent capable of dissolving the release matrix, the active principle and the transcutaneous absorption promoter and also capable of being rapidly removed by evaporation on contact with the skin.
Inventors:
Sonar, Henri
Bridget, Irel
Bridget, Irel
Application Number:
JP52902496A
Publication Date:
May 24, 2006
Filing Date:
March 29, 1996
Export Citation:
Assignee:
Sanofi-Aventis
International Classes:
A61K47/38; A61K9/28; A61K9/30; A61K9/32; A61K9/36; A61K9/70; A61K31/55; A61K31/551; A61K31/565; A61K47/30; A61P25/00
Domestic Patent References:
| JP7165611A | ||||
| JP1149722A | ||||
| JP63307815A |
Foreign References:
| WO1994013257A1 | ||||
| WO1995009195A1 |
Attorney, Agent or Firm:
Aoyama Aoi
Mitsuo Tanaka
Mitsuo Tanaka
Previous Patent: インシュリン依存性糖尿病（ＩＤＤＭ）患者に作用する免疫反応および免...
Next Patent: グリセロール−３−リン酸アシルトランスフェラーゼをコードするＤＮＡ...
Next Patent: グリセロール−３−リン酸アシルトランスフェラーゼをコードするＤＮＡ...